" /> Governor Abbott, DSHS Announce Distribution Of COVID-19 Antibody Therapy To Hospitals Across Texas – EastTexasRadio.com
Titus Regional Orthopedic Sports Medicine Header
Morrell banner
Mid America Pet Food Header
Sandlin – Find New Roads – It’s All About You Aug 2017
Momentum Polaris Get Outside Now
cypress basin hospice
Hess Lawn Mower Header

Governor Abbott, DSHS Announce Distribution Of COVID-19 Antibody Therapy To Hospitals Across Texas

Today, Governor Greg Abbott announced that the Texas Department of State Health Services (DSHS) is allocating an initial shipment of bamlanivimab, the Eli Lilly & Company monoclonal antibody therapy, to be distributed as early as next week to acute care hospitals across every geographic region of the state. These weekly shipments of doses have been provided to Texas at no cost through the U.S. Department of Health and Human Services.

DSHS will allocate this initial distribution of bamlanivimab based on three criteria: new confirmed cases of COVID-19 in the community, new lab-confirmed COVID-19 admissions to hospitals, and total lab-confirmed COVID-19 patients in hospitals.

“This initial allotment of bamlanivimab will help health care professionals effectively treat cases of COVID-19 within their communities and aid in reducing hospitalizations,” said Governor Abbott. “I thank the U.S. Department of Health and Human Services for providing Texas with this crucial antibody therapy that will help keep Texans safe and mitigate the spread of COVID-19.”

Bamlanivimab is for outpatient use in people who have tested positive for COVID-19 and are at increased risk of severe disease. It shows to prevent hospitalizations in some patients when used before they become very sick.